Literature DB >> 7018236

Drug-induced lupus: an adjuvant disease?

R T Schoen, D E Trentham.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7018236     DOI: 10.1016/0002-9343(81)90250-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

1.  Transient monoclonal gammopathy in hydralazine induced lupus erythematosus.

Authors:  Y Shoenfeld; D Isenberg
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

Review 2.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Effect of 1,1-dimethylhydrazine on lymphoproliferation and interleukin 2 immunoregulatory function.

Authors:  R M Bauer; M J Tarr; R G Olsen
Journal:  Arch Environ Contam Toxicol       Date:  1990 Jan-Feb       Impact factor: 2.804

4.  Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro.

Authors:  T Ochi; E A Goldings; P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

Review 5.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

6.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.